Finding oncology data can be daunting. There are lots out there, but there are only specifics that you need.
Precise oncology laboratory data is now even more important in current medicine. Oncology treatments and diagnostics rely a lot on data from genomic test results, pathology reports, and molecular assays.
Using claims data and oncologist referral information to find precision oncology datasets that make things easier.
If done right, it will also reveal the real-world of physicians, patients, and labs. We made this blog for healthcare systems and sales teams that need to find precise oncology datasets.
What Precision Oncology Datasets You Need?
Although most teams already have this clearly defined, it is worth going back to know what are the exact data sets you need. Keep in mind that datasets are diverse and there could be a lot of providers out there.
Some useful datasets include genomic tests, pathology or therapy reports, outcome data, etc.
Regardless, the dataset should be defined in the first place and useful to you.
Utilizing Oncologist Referral Information
Referral data shows the pattern on which physicians refer patients for specific tests, and how care coordination happens across specialties.
It highlights the flow between primary care, oncology, and pathology, and also who does the decision-making.
Referral analysis also helps detect referral leakage, measure collaboration across hospital systems, and locate new partnership opportunities for labs and diagnostics.
Using Claims Data for Oncology Insights
Claims data provides a broad view of healthcare activity. It shows who is ordering specific tests, the procedures, where services are performed, and which patient populations are being reached.
In oncology, claims can uncover:
- Patterns in molecular or genomic test utilization
- The top ordering oncologists or pathologists for each cancer subtype
- Regional differences in diagnostic adoption
By analyzing billing and procedure codes, organizations can understand real-world testing behavior and discover new opportunities to improve access.
Case Example: Mapping Breast Cancer Testing Networks
To understand how claims and referral data work together in practice, consider a real-world example in cancer diagnostics. Let’s do breast cancer, specifically around HER2 and BRCA testing.
The team begins by using claims data to identify oncologists who frequently bill for HER2 or BRCA genetic tests. These billing patterns help pinpoint which providers are most active in precision oncology testing and where testing volumes are concentrated geographically.
The claims data also reveals which laboratory partners process these tests and the frequency of repeat or follow-up testing.
Next, the team overlays referral data to uncover the physician relationships that drive testing demand. Referral linkages show which surgeons or pathologists most often send patients to those oncologists for follow-up genetic evaluation or treatment planning.
In many cases, this exposes high-value referrals or the clinicians who consistently collaborate on patient care but may not be formally affiliated through the same health system.
How Voyager Simplifies Oncology Dataset Discovery
By combining these two data sources, labs and science companies can discover oncology laboratory datasets. This allows for better outreach planning, collaboration with top referrers, and a deeper understanding of real-world testing behavior in cancer care.
Platforms like Voyager make this type of network analysis scalable by linking claims, referrals, and lab data into a unified precision oncology map.
FAQ Section (for SEO and Schema)
Q1. What types of data are included in a precision oncology data set?
They include molecular testing results, pathology findings, claims data, and provider referral linkages that together describe a patient’s diagnostic and treatment pathway.
Q2. How does claims data improve oncology research?
Claims data highlights where and by whom oncology tests are ordered, revealing patterns in utilization and patient access.
Q3. What insights come from analyzing oncologist referral data?
Referral data exposes how patients move between specialists and labs, identifying influential referrers and potential referral leakage.
Q4. How can labs or biopharma integrate these datasets?
By linking claims, lab orders, and referral networks through platforms like Voyager, teams can identify key oncologists and better understand diagnostic adoption.
Q5. What are the benefits of combining claims and referral data?
It creates a unified view of provider behavior, helping organizations improve precision oncology access, referral efficiency, and market intelligence.
